Skip to content
OpenCapital
Get started

Baxter International BAX Healthcare Systems & Technologies — Segment operating income

Other segment segments

Reportable Segment
$298M-25.5%
Medical Products & Therapies
$186M-23.8%
Pharmaceuticals
$46M-27.0%

Similar metrics at other companies

STERIS logo
STEHealthcare — Segment operating income
$258.1M+4.5%
STERIS logo
STEHealthcare [Member] — Segment operating income
$246.92M+10.3%
Fortive logo
FTVAdvanced Healthcare Solutions — Operating profit (loss)
$32.7M+50.7%
Cognizant logo
CTSHHealthcare Segment — Income from operations
$315M+9.4%
Cognizant logo
CTSHHealthcare — Income from operations
$368M-9.1%
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Income from operations
$161M+24.8%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's healthcare systems & technologies — segment operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's healthcare systems & technologies — segment operating income?
Baxter International (BAX) reported healthcare systems & technologies — segment operating income of $66M in Q1 2026.
How has Baxter International's healthcare systems & technologies — segment operating income changed year-over-year?
Baxter International's healthcare systems & technologies — segment operating income decreased by 29.0% year-over-year, from $93M to $66M.
What is the long-term trend for Baxter International's healthcare systems & technologies — segment operating income?
Over 3 years (2021 to 2025), Baxter International's healthcare systems & technologies — segment operating income has grown at a 94.4% compound annual growth rate (CAGR), from $60M to $441M.
What does healthcare systems & technologies — segment operating income mean?
The profit earned by the segment from its core business activities before interest and taxes.
How do you interpret healthcare systems & technologies — segment operating income?
Higher operating income indicates better profitability and operational control.
How does healthcare systems & technologies — segment operating income compare across companies?
A standard profitability metric used to compare the performance of business units across diversified healthcare companies.